triaziquone has been researched along with Carcinoma, Papillary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Limburg, H | 1 |
| Heckmann, U; Limburg, H | 1 |
2 other study(ies) available for triaziquone and Carcinoma, Papillary
| Article | Year |
|---|---|
[Cytostatic treatment of genital carcinoma].
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Carcinoma, Papillary; Cyclophosphamide; Female; Genital Neoplasms, Female; Germany, West; Humans; Methotrexate; Ovarian Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Thiotepa; Triaziquone; Uterine Cervical Neoplasms; Uterine Neoplasms; Vinblastine | 1969 |
Chemotherapy in the treatment of advanced pelvic malignant disease with special reference to ovarian cancer.
Topics: Adenoma; Antineoplastic Agents; Carcinoma, Papillary; Culture Media; Culture Techniques; Endometrium; Female; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Triaziquone; Uterine Cervical Neoplasms | 1968 |